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Zebrafish as a Model Organism for the Identification
and Characterization of Drugs and Genes
Affecting p53 Signaling
Zebrafish embryos that had been bathed for 6 hr in
a medium containing camptothecin were retarded in
development and showed dark tissues, especially in the
head; the tail tip was also kinked down (Figure 1A).
Camptothecin induced a strong increase in apoptosis,
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Germany as revealed by the TUNEL assay (terminal-deoxynucleo-
tide-transferase-mediated dUTP-digoxygenin nick-end-
labeling staining). Cells, most likely neurons, in the brain,
the eye, and the spinal chord were predominantly la-Summary
beled (Figure 1E). In contrast, if p53-deficient embryos,
induced by injection of antisense p53 morpholinos, werep53 and its main negative regulator, Mdm2, are key
exposed to camptothecin, only a slight growth retarda-players in mammalian cancer development. Activation
tion and kinked tail was observed (Figure 1B). Darkeningof the transcription factor p53 through DNA damage
of the brain tissue as well as the increase in apoptosisor other stresses can result in cell cycle arrest, apopto-
induced by camptothecin was strongly suppressed insis, or both [1, 2]. Because of the absence of character-
the p53-deficient embryos (Figure 1F). Thus, it can beized p53 signaling in zebrafish (Danio rerio), we have
concluded that the camptothecin-induced apoptosis instudied the roles of Mdm2 and p53 in zebrafish by
zebrafish embryos, as in mammalian cells, resultedgenerating early embryonic knockdowns and exam-
solely from an increase in p53 activity, caused by DNAined the involvement of p53 in DNA damage-induced
damage [5, 6].apoptosis. p53-deficient embryos, induced by injec-
Several in vivo control experiments have been per-tion of antisense morpholinos, were morphologically
formed (see also the Supplementary Material availableindistinguishable from control embryos, when unper-
with this article online). A p53 morpholino at a secondturbed, whereas Mdm2 knockdown embryos were se-
site induced the same effects as the p53 morpholinoverely apoptotic and arrested very early in develop-
used in the experiments described above; inverted-ment. Double knockdowns showed that p53 deficiency
sequence and four-base mismatch p53 morpholinos didrescued Mdm2-deficient embryos completely, similar
not induce rescues. Furthermore, in an in vitro transcrip-to observations in mice. p53 deficiency also markedly
tion/translation system the p53 morpholino inhibiteddecreased DNA damage-induced apoptosis, elicited
protein translation from p53 mRNA specifically; no inhi-by ultraviolet irradiation or by the anti-cancer com-
bition of translation by four-base mismatch p53 morpho-pound camptothecin. p21/Waf/Cip-1 appeared to be
linos was induced (data not shown).a downstream target of zebrafish p53, as revealed
Ultraviolet (UV) irradiation has also been demon-relative p21 mRNA levels determined via TaqMan anal-
strated to induce an increase in p53 levels in variousysis. In contrast to mammals, zebrafish may regulate
mammalian systems, in part because of posttransla-p53 activity by using an internal polyA signal site. We
tional stabilization of p53 [7]. Similar to the camptothecinconclude that zebrafish represents a promising model
exposure, a short exposure to UV caused zebrafish em-organism for future compound-based and genetic
bryos to show growth retardation, kinked tails, and ascreens and believe that it will help to identify and
strong increase of apoptosis a few hours later (Figurescharacterize new anticancer drugs and new targets
1I and 1M). Compared to buffer-injected irradiated con-for cancer treatment.
trols, p53-deficient embryos, exposed to UV, did not
show any increase in TUNEL-positive cells (Figures 1N
Results and Discussion and 1M), although the morphology was similarly affected
(Figures 1I and 1J). Thus, results obtained with cultured
In more than 50% of human tumors, the p53 gene is mammalian cells could be reproduced for the first time
mutated [3], and the loss of p53-mediated apoptosis on a whole-organism level in zebrafish.
and cell cycle control has been implicated as an impor- Recently, it has been shown that cyclin-dependent
tant event in tumor progression in a number of systems. kinase inhibitor roscovitine stabilizes and activates nu-
There is still a considerable lack of data about the suit- clear p53, possibly via a potent downregulation of Mdm2
ability of zebrafish (Danio rerio) in cancer research stud- transcript and protein level [8]. This finding is supported
ies, and therefore we examined if the p53 function is by the fact that, compared to controls, p53-deficient
evolutionarily conserved between zebrafish and mam- zebrafish embryos exposed to roscovitine were less re-
mals. The efficacy of a variety of cancer therapies in tarded (Figures 1K and 1L) and less apoptotic (Figures
vivo depends on the ability to induce a p53-mediated 1O and 1P).
apoptotic response. The human topoisomerase I inhibi- During early embryonic development, the p53-defi-
tor camptothecin, for example, is known to create DNA cient embryos could not be distinguished morphologi-
strand breaks that probably induce repair or apoptosis cally from the control embryos (Figures 1C and 1D); also,
mechanisms via p53 [4]. the numbers of apoptotic cells (Figures 1G and 1H) and
proliferative cells, labeled for phosphorylated histone-
H3 (data not shown), were not affected by p53 defi-1Correspondence: u.langheinrich@exelixis-de.com
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Figure 1. Induction of Apoptosis, Either by Drugs or Ultraviolet Irradiation, was Suppressed in p53-Deficient Embryos
(A, B, E, and F) Embryos were bathed in 500 nM camptothecin at 24 hpf and photographed or fixed for TUNEL staining 6 hr later; (I, J, M,
and N) embryos were exposed to 400 mJ/cm2 ultraviolet light (254 nm) at 24 hpf and 6 hr later photographed or fixed for TUNEL staining. (C)
Buffer-injected control embryo; (D) p53-deficient embryo; (K and L) 24 hpf embryos exposed to 50 M roscovitine between 6 and 24 hpf; (O
and P) embryos exposed to 100 M roscovitine between 6 and 48 hpf. (A, C, E, G, I, K, M, and O) Embryos were injected with buffer at the
1- to 4-cell stage. (B, D, F, H, J, L, N, and P) Embryos were injected with 3 ng p53 morpholino at the 1- to 4-cell stage. (A, B, C, D, I, J, K,
and L) Phase contrast. (E, F, G, H, M, N, O, and P) TUNEL staining. The figure shows a lateral view, anterior is to the left, and the scale bar
represents 500 m.
ciency. However, the knockdown was functionally ac- E5.5 [12, 13]. Because Mdm2 is a negative regulator
of p53 function, the most probable explanation for thetive, as shown by the modified stress responses. Thus,
p53 appears to be dispensable for early development observed zebrafish phenotype is that p53 functions
were not suppressed in the Mdm2-deficient embryosof zebrafish, a similar result to that obtained with p53
null mice, which also develop normally and only later in and that this led to growth arrest, apoptosis, or both.
Upon closer examination of the Mdm2-deficient em-development are prone to spontaneous tumor develop-
ment [9]. bryos, the TUNEL assay revealed a very strong increase
in the number of apoptotic cells, especially in the brain,The proto-oncogene MDM2, which is frequently am-
plified in human tumors, acts as a potent inhibitor of the eyes, and the spinal chord (Figures 2L and 2M),
whereas the number of proliferative, phosphorylatedp53 transactivation function and has been shown to
induce the rapid degradation of p53 through ubiquitin- H3-histone-positive cells was only slightly reduced as
compared to controls (Figures 2P and 2Q). Thus, wemediated proteolysis. This feedback loop ensures the
short-term nature of p53 induction and allows cells to conclude that the observed growth arrest and tissue
degradation in the Mdm2-deficient zebrafish embryoscontinue the cycling after repairing their DNA [10, 11].
With increasing amounts of injected Mdm2 morpho- mainly resulted from an increase in apoptosis.
Similarly, close examination of the Mdm2 null micelino, a gradual increase in growth retardation and tissue
darkening could be observed in 1-day-old zebrafish em- revealed that embryos die by induction of apoptosis at
3.5 dpc (G. Lozano, unpublished observations in [14]).bryos (Figures 2A–2C). In the strongest phenotype,
growth of head and tail structures was severely sup- Also, in cell cultures loss of Mdm2 has been shown to
induce the p53-dependent apoptotic pathway [15].pressed, indicating an early developmental block; also,
a strong general tissue darkening was observed. Pheno- The main functional domains as well as the interaction
between Mdm2 and p53 are conserved in zebrafish [16,typic classes could not be distinguished within one
treatment, the penetrance being always high; in most 17], suggesting that in zebrafish the Mdm2/p53 autoreg-
ulatory loop is functional. To test this assumption, wecases, more than 90% of the embryos displayed a rela-
tively uniform phenotype. The effect of Mdm2 deficiency coinjected the Mdm2 and the p53 morpholino to induce
simultaneous p53 and Mdm2 deficiencies. We used dif-in zebrafish was similar to the effect of Mdm2 knockout
in mice. Embryos exhibited an abnormal embryonic ar- ferent ratios of the Mdm2 and p53 morpholino amounts
injected in order to titrate the response. Even the mostchitecture and an early developmental block, and the
most developed embryo had not progressed beyond severely lethal Mdm2 knockdown phenotypes could be
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Figure 2. Complete Rescue of Growth Retardation, Apoptosis, and Lethality in Mdm2-Deficient Embryos by a Simultaneous p53 Deficiency
The response was titrated via an increase in the amount of the injected p53 morpholino. A partial rescue of Tsg101 deficiency was obtained
by simultaneous p53 deficiency. All rescue experiments were performed by coinjection of two different morpholinos, as indicated. (A–C and
E–S) Mdm2 knockdown with or without simultaneous p53 knockdown. (D) Injection of five-base mismatch control Mdm2 morpholino. (V–Y)
Tsg101 knockdown with or without simultaneous p53 knockdown. (A–J, N, R, T, V, and X) Phase contrast. (K, O, S, and U) Acridine orange
staining; apoptotic cells are visible as bright green spots, and less bright homogenous green staining is unspecific background staining. (P
and Q) Staining for phosphorylated Histone-H3. (L, M, W, and Y) TUNEL staining. (A–F and J–Y) 24 hpf embryos; (G and H) 48 hpf embryos;
(I) 5 dpf embryos. The figure shows a lateral view, except (E) and (I), which are dorsal views. Anterior is to the left, and the scale bar represents
500 m.
completely rescued (100% of the embryos tested) if the Very low ratios of the amounts of the p53 and Mdm2
morpholino (0.3 and 6 ng, respectively) were sufficientMdm2 morpholino was coinjected with sufficient amounts
of the p53 morpholino (compare Figure 2C with 2R). The for a complete rescue at 2 dpf (compare Figures 2G and
2H). Embryos developed swim bladders at 5 dpf andnumbers of apoptotic (Figure 2S) and proliferating (data
not shown) cells in the rescued embryos were similar were morphologically indistinguishable from buffer-
injected control embryos. Further reductions in theto control embryos.
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amount of the coinjected p53 morpholino resulted in a
gradual increase of the phenotypic strength; this in-
crease generated a phenotypic series resembling the
phenotypes observed with an increasing grade of Mdm2
deficiency (e.g., Figure 2J). Acridine orange staining of
live embryos indicated that the higher the amount of the
coinjected p53 morpholino, the fewer apoptotic cells
were visible (Figures 2K, 2O, and 2U). Thus, absence of
p53 rescued Mdm2-deficient zebrafish embryos from
growth suppression, apoptosis, and lethality in a con-
centration-dependent manner. By this rather simple ap-
proach, double-injection of two antisense morpholinos,
we were able to quickly reproduce data obtained from
p53/Mdm2 double knockout mice, which also develop
normally and are viable [12, 13]. Thus, as in mice, the
primary function of Mdm2 during zebrafish development
appears to be the negative regulation of p53 activity.
Several in vivo control experiments have been per-
formed with second-site (six different morpholinos tested)
and mismatch Mdm2 morpholinos (e.g., Figures 2D, 2E,
2F, and 2I; see also Supplementary Material). All Mdm2
morpholinos, except the mismatch morpholino, induced
phenotypes similar to those described above, and all
phenotypes could be rescued by coinjection of the p53
morpholino (the same results were obtained with a
second-site p53 morpholino). Injection of inverted-
sequence and four-base mismatch p53 morpholinos,
respectively, did not induce a rescue of Mdm2-deficient
embryos. Furthermore, in an in vitro transcription/trans-
lation system the potency and specificity of the Mdm2
morpholinos have been tested. The Mdm2 morpholino
inhibited protein translation of Mdm2 mRNA specifically;
no inhibition of translation by five-base mismatch Mdm2
morpholinos was induced (data not shown).
Because we did not try to rescue the Mdm2-deficient
embryos by injection of Mdm2 mRNA, we cannot ex-
clude the possibility that the Mdm2 morpholinos in-
duced additional or even solely unspecific effects. In
this case, the observed phenotypes would not result
from a knockdown of the Mdm2 protein but might beFigure 3. Analysis of the p53 and p21 Expression Pattern and Ex-
due, for example, to toxic effects. Similarly, althoughpression Levels
quite unlikely, the p53 morpholinos used might havep53 transcript levels were increased after various treatments, as
caused unspecific anti-toxic effects (no rescues wereshown by whole-mount in situ histochemistry (A–F) and by Northern
analysis (G–I). For whole-mount in situ histochemistry, panels show tried with p53 mRNA).
the following: (A) control; (B) embryos that were exposed to 500 nM The tumor susceptibility gene Tsg101 has been shown
camptothecin between 24 and 30 hpf; (C) embryos that were ex- to inhibit MDM2 decay via its ubiquitin-conjugating do-
posed to 400 mJ/cm2 UV at 24 hpf and fixed at 30 hpf; (D) Mdm2- main and thereby decrease p53 levels [18]. Homozygousdeficient embryos with a moderate phenotype, (E) Mdm2-deficient
embryos with a strong phenotype; and (F) magnification of the tail
region of (E). All embryos were fixed at 30 hpf, and are shown in a
lateral view with anterior to the left; the scale bar represents 500
m except in F, where the bar is 100 m. (G) Northern Blot analysis p53-deficient embryos (lane 9), p53-deficient embryos treated with
of the p53 mRNA levels at 30 hpf under various treatments. Total 500 nM camptothecin between 24 and 30 hpf (lane 10), embryos
RNA was obtained from embryos under various treatments at 30 treated with 50 M roscovitine between 6 and 24 hpf (lane 11), and
hpf and subsequently separated on agarose gels. The different RNA p53-deficient embryos treated with 50 M roscovitine between 6
samples separated were obtained from the following: control em- and 24 hpf (lane 12). (H) The loading control for lanes 1–5 was
bryos from experiment I (lane 1), Mdm2-deficient embryos of the methylene blue staining of the gel, and (I) the loading control for
moderate phenotype (lane 2), camptothecin-treated embryos from lanes 7–12 was hybridization of a similar blot with an actin probe.
experiment I, in which embryos were exposed to 50 nM campto- Experiments I and II were two completely independent experiments.
thecin beween 24 and 30 hpf (lane 3), camptothecin-treated em- (J) TaqMan analysis of relative p21 mRNA levels in zebrafish knock-
bryos from experiment I, in which embryos were exposed to 500 down embryos and embryos exposed to drugs or to UV. Specific
nM camptothecin beween 24 and 30 hpf (lane 4), embryos exposed p21 mRNA levels were expressed as the fold difference between
to UV light (lane 5), Tsg101-deficient embryos of the moderate phe- the conditions compared (untreated, buffer-injected control em-
notype (lane 6), control embryos from experiment II (lane 7), campto- bryos have a value of 1). Data are representative for two completely
thecin-treated embryos from experiment II, in which embryos were independent experiments. Treatments were the same as those used
exposed to 500 nM camptothecin beween 24 and 30 hpf (lane 8), for the Northern Blot analysis. Data have been normalized to actin.
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Figure 4. Model Showing Functional Interac-
tions of TSG101, MDM2, and p53 as Well as
Their Modulation by Drugs and Irradiation
Red arrows indicate interactions that are
likely to be conserved in zebrafish and mam-
mals, according to the data presented. Path-
ways with gray arrows have not been ana-
lyzed in zebrafish.
Tsg101 knockout mice do not develop beyond E6.5 and internal polyA signal site, which is present in zebrafish
p53, in the treatments that are supposed to activatedisplayed very high p53 protein levels, strongly in-
creased p21/WAF/Cip-1 mRNA levels, and decreased p53. Another explanation would be alternative splicing,
reported in rodents [21] and certain normal human andcellular proliferation. p53 deficiency partially rescued
the Tsg101 / mice [19]. Tsg101 deficiency in zebra- cancer cells for p53 [22]. To our knowledge, usage of
an internal polyA signal site has not been published sofish induced a phenotype similar to that obtained by
injection of the Mdm2 morpholino; embryos were se- far for the p53 transcript. This feature might indicate a
special zebrafish-specific step in regulating p53 activity,verely retarded and apoptotic (Figures 2V and 2W). p53
deficiency partially rescued Tsg101-deficient embryos e.g., the shorter transcript might have a higher stability
than the longer one. However, we cannot exclude thefrom apoptosis (Figures 2X and 2Y) and growth retarda-
tion, as it did in the Tsg101/p53 mice double knockouts, possibility that the occurrence of two p53 transcripts
might reflect gene duplication, a rather common eventand embryos died at 2 dpf.
in zebrafish.
In order to evaluate if p21/Waf/Cip-1 is a downstreamInduction of the p53 and p21 Transcript levels
Whole-mount in situ hybridization indicated that the p53 target of the transcription factor p53, we performed a
TaqMan analysis to determine the relative p21 mRNAtranscript levels of camptothecin-bathed, Mdm2-defi-
cient, and UV-irradiated embryos had increased, partic- levels in whole zebrafish embryos under various treat-
ments. Knockdown of Mdm2 and Tsg101 induced anularly in the brain and spinal chord (Figure 3). Northern
analysis showed the occurrence of the known 2.2 kb increase in the p21 mRNA levels by factors of 4 and
13, respectively. The highest inductions were observedp53 mRNA transcript [16] in controls but also showed
a second strongly stained 1.7 kb p53 mRNA in zebrafish after camptothecin (32-fold) and roscovitine (33-fold)
treatment (Figure 3J). When the same experiments wereembryos treated with camptothecin or roscovitine and
in embryos with Mdm2 or Tsg101 deficiency (Figures performed in p53-deficient embryos, the induction of
the p21 mRNA was strongly suppressed (Figure 3J).3G–3I). In p53-deficient embryos, however, campto-
thecin exposure did not induce expression of the second These data fit quite well to the increased p21 mRNA
levels previously reported for Tsg101 knockout mice [19]transcript (compare lanes 8 and 10).
p53 has been shown to autoregulate its own transcrip- and to experiments with human cell cultures exposed to
camptothecin [23] and roscovitine [7]. Thus, p53 ap-tion, and exposure of mouse cells to genotoxic agents
resulted in an increase in p53 mRNA levels and in p53 pears to act as a transcriptional activator of p21 in zebra-
fish, as shown for several mammalian systems [2].promoter activation [20]. Our data suggest that in zebra-
fish an autoregulatory loop might also work, but in a Upregulation of the p21 level in the Mdm2 and Tsg101
knockdown embryos as well as in the drug- and UV-different way. A simple explanation for the occurrence
of the induced 1.7 kb transcript would be usage of the treated zebrafish was likely one of the main reasons for
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